US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 134 actively recruiting studies with Louisiana sites out of 134 registered in total. The busiest research areas in Louisiana are Obesity, Systemic Lupus Erythematosus, Endometrial Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), Novartis Pharmaceuticals, Pennington Biomedical Research Center. By stage, Louisiana trials break down as Phase 1 (12), Phase 2 (27), Phase 3 (57), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
134
Recruiting Now
134
← Back to US Map
Top Conditions in Louisiana
Obesity (4)Systemic Lupus Erythematosus (3)Endometrial Cancer (3)Asthma (2)Prostate Cancer (2)Interstitial Lung Disease (2)Acute Myeloid Leukemia (2)Stroke (2)Prostatic Neoplasms, Castration-Resistant (2)Acne (2)Lung Non-Small Cell Carcinoma (2)Melanoma (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 134 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 134. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Obesity, Systemic Lupus Erythematosus, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT07477587 Phase 1
Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenic...
Condition
Multiple Myeloma (MM)
Enrollment
258 pts
Location
United States, Australia, China
Sponsor
Shanghai Henlius Biotech
View Trial →
NCT07094204 Phase 1
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Condition
Solid Tumor
Enrollment
364 pts
Location
United States, France, Japan
Sponsor
Astellas Pharma Inc
View Trial →
NCT07398417 Phase 3
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal ...
Condition
Fibromyalgia
Enrollment
620 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06133972 Phase 3
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participant...
Condition
Systemic Lupus Erythematosus
Enrollment
550 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Condition
Gout
Enrollment
500 pts
Location
United States, Poland, Spain
Sponsor
Crystalys Therapeutics
View Trial →
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05639465 N/A
Recruiting
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Child...
Condition
Emotional Distress
Enrollment
800 pts
Location
United States
Sponsor
University of Illinois at Urba
View Trial →
NCT06312722 N/A
Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market S...
Condition
Benign Prostatic Hyperplasia
Enrollment
92 pts
Location
United States
Sponsor
Urotronic Inc.
View Trial →
NCT06976112 N/A
Recruiting
Impact of Lean Pork on Endothelial Function in Perimenopause
Condition
Cardiovascular Outcome
Enrollment
30 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT06102330 N/A
Recruiting
Multicenter HomeVENT: Home Values and Experiences Navigation Track
Condition
Pediatric ALL
Enrollment
600 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT06070194 N/A
Recruiting
Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Exten...
Condition
Sleep Deprivation
Enrollment
100 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT04986423 Phase 2
Recruiting
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castrat...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
200 pts
Location
United States, China
Sponsor
Zenith Epigenetics
View Trial →
NCT07409103 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat ...
Condition
Active Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, South Africa
Sponsor
Elevara Medicines Limited
View Trial →
NCT06151405 N/A
Recruiting
Nutrition for Asthmatics
Condition
Asthma
Enrollment
15 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT06835686 N/A
Recruiting
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities ...
Condition
Obesity
Enrollment
522 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04588922 Phase 1, Phase 2
Recruiting
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Pa...
Condition
Hematologic Malignancies
Enrollment
160 pts
Location
United States, China
Sponsor
Sellas Life Sciences Group
View Trial →
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT05835310 Phase 3
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus ...
Condition
Systemic Lupus Erythematosus
Enrollment
100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT05892614 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patie...
Condition
Interstitial Lung Disease
Enrollment
25 pts
Location
United States
Sponsor
aTyr Pharma, Inc.
View Trial →
NCT06279013 N/A
Recruiting
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and P...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
Page 1 of 6 — 134 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology